Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Anxiety Disorders and Depression Treatment Market 2016: Global Industry Research, Supply, Consumption and Prospects to 2022

Friday, October 7, 2016 6:26
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Latest industry research report on: Global Anxiety Disorders and Depression Treatment Market 2016: Industry Research, Size, Shares, Key Trends, Demand, Growth to 2022

Depression and Anxiety Disorders are the most common psychiatric disorders affecting a huge population across the globe. Depression; is related to a state Of emotion that further affects actions, thoughts and sometimes the sleeping pattern Of the concerned person. Depression is the most common type Of mental disorder affecting nearly 350 million patients Of varied scale age groups, whereas, anxiety is a reaction to stress. Extreme level Of anxiety result in anxiety disorders which include phobias, obsessive-compulsive disorder, panic disorder, post-traumatic based stress disorder.

The rising geriatric population, reduced side effects and greater efficacy Of new/innovative drugs along with the accelerating prevalence Of anxiety & depression disorders are contributing towards the growth Of this market. However, patent expiry for majority Of the drugs, dry pipeline for the novel drugs, mental disorders that are drug-resistant and growing numbers Of different generic drugs are analysed to impede the anxiety disorders and depression treatment market growth. The prospect Of innovations and developments in herbal remedies with an improved distribution network is Offers potential opportunities for the key participants.

Get Free Sample Report Of Anxiety disorders and depression treatment Market :

The global anxiety disorders and depression treatment market is segmented on the basis Of drug class, pipeline analysis and geography. The drug class segment is further categorized into SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers and Others. On the basis Of pipeline analysis, the market is segmented into Brintellix (Vortioxetine – Lu AA21004), ALKS-5461 and Brexpiprazole (OPC-34712).
The progressive outcomes Of clinical trials for the related drugs and their anticipated commercialization in the forecast period will drive the growth for anxiolytic and antidepressant drugs in the future. Geographically, the global anxiety disorders and depression treatment market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America accounts for the largest market share, contributed by the U.S. due to the presence Of various branded formulations influencing the market dynamics extensively.

Have Any Query? Ask Our Expert @

Key companies prOfiled in this market include Eli Lilly and Company, Forest Laboratories, Inc., AstraZeneca PLC, SanOfi-Aventis, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson and others. Recent developments, Clinical research, geographical expansion and enhanced distribution networks are the key strategies adopted by the key participants.


  • In-depth coverage Of the global anxiety disorders and depression treatment market including key drivers, restraints and opportunities would help prOfessionals to better understand market inclination
  • Drug class market is comprehensively analyzed on the basis Of drug launch, expiry, sales/revenue, efficacy Of the drugs and geographical presence Of market leaders
  • The projections in the report are made by analyzing the current market trends and future market potential for the period Of 2013-2020 in terms Of value
  • Detailed study Of the strategies Of key leaders, partnerships and acquisitions in the global anxiety disorders and depression treatment market would be informative for prOfessionals in the corporate sector
  • Pin-point analysis Of geographic segments helps to identify opportunities for growth within the anxiety disorders and depression treatment Market
  • Identification Of key investment pockets for anxiety disorders and depression treatment market, provide strategic assistance to decision makers
  • Market attractiveness analysis, has been included for various product segments, therapeutics, devices and geographic regions along with a detailed analysis Of factors responsible for rapid growth Of the market segments

The global anxiety disorders and depression treatment Market is segmented into three major categories: drug class, pipeline analysis and geography.


  • SSRIs (Selective Serotonin Reuptake Inhibitors)
  • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
  • TeCAs (Tetracyclic Antidepressants)
  • TCAs (Tricyclic Antidepressants)
  • MAOIs (Monoamine Oxidase inhibitors)
  • Atypical Antipsychotics
  • Benzodiazepines
  • Anticonvulsants
  • Beta-Blockers
  • Others
  • Brintellix (Vortioxetine – Lu AA21004)
  • ALKS-5461
  • Brexpiprazole (OPC-34712)


  • North America
  • Europe
  • Asia-Pacific

About Custom Market Insights:

Market Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.

Custom Market Insights is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive.

What makes us different from our competitors?

Compared to our competitors, our offerings include, but are not limited to market research services on latest industry trends, customized study at reasonable price, and database bigger than our competitors and provide more relevant results to fit your needs.

Contact Us

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.